Project Grant HT94252310510
Award Date
9/1/23
Completion Date
8/31/27
Dollars Obligated
$2.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
This Project Grant award of $1,008,313.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives at the University of California, San Francisco (UCSF). The funding will enable UCSF to conduct innovative research focused on transforming healthcare for military service members and the broader public, with a particular emphasis on addressing critical medical challenges such as cancer,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...
This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...
This federal Project Grant award, valued at $993,283.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports biomedical research focused on advancing understanding of multiple sclerosis progression, to be conducted by the University of California, San Francisco (UCSF) over a period from September 1, 2025 to August 31, 2027. The research aims to identify proteomic determinants and components that drive the...
This federal Project Grant award in the amount of $565,250 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "ATP CITRATE LYASE AS A DRUGGABLE VULNERABILITY IN MUTANT ISOCITRATE DEHYDROGENASE GLIOMAS", will support research conducted by The Regents of the University of California, San Francisco (UCSF) from September 1, 2024 through August 31, 2027. The research aims to investigate ATP citrate...
This federal Project Grant award in the amount of $1,041,595.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. Specifically, the grant will fund innovative and impactful research on melanoma conducted by The Regents of the University of California, San Francisco (UCSF), a prominent...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
The U.S. Department of Defense's Defense Health Agency awarded a $2,433,748.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) for the "DECISION SUPPORT TOOLS ADDRESSING TRAUMATIC BRAIN INJURY IN BRIDGE (STAT-BRIDGE)" project under the Military Medical Research and Development (CFDA 12.420) federal grant program. This award, with a performance period from June 1, 2025 to May 31, 2029, will support UCSF's research efforts to develop innovative decision...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...